论文部分内容阅读
本文探讨小剂量米非司酮配伍米索前列醇阴道后穹隆放药用于中期引产的可行性。３２例采用此方法，３２例利凡诺羊膜腔内注射引产作对比。从宫缩至胎儿、胎盘娩出，米索组（５．１２小时±２．５２小时）明显少于利凡诺组（８．３０±４．０５小时）；引产平均出血量，米索组（７５．６３±３７．９１ｍｌ）明显少于利凡诺组（１５２．３４±４０．５１ｍｌ）；胎盘、胎膜滞留及清宫，米索组（１２．５％）明显低于利凡诺组（６２．５％）；结果表明：小剂量米非司酮口服配伍阴道后穹隆放入米索前列醇进行中期引产效果明显优于利凡诺引产。
This article discusses the feasibility of using small doses of mifepristone combined with misoprostol vaginal fornix drug delivery for mid-term induction of labor. 32 cases using this method, 32 cases of rivanol amniotic cavity injection for induction of labor for comparison. From contractions to fetus, the placenta was delivered, the misoprostol (5.12 hours ± 2.52 hours) was significantly less than rivanol group (8.30 ± 4.05 hours) 75.63 ± 37.91ml) was significantly lower than that of rivanol group (152.34 ± 40.51ml); placenta, fetal membrane retention and clearance, misoprostol (12.5%) were significantly lower than the rivanol group 62.5%). The results showed that the small dose of mifepristone oral compatibility vaginal posterior vaginal for misoprostol mid-term induction of labor was significantly better than rivanol abortion.